Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wonder why you write so many wrong things after reading that slide...OMG
That slide doesn't imply at all that all placebo patients progressed. That slide states that of all placebo patients, some had no progression/recurrence, some had progression/recurrence and chose to go on with other treatment, some had progression/recurrence and chose to take DcVAX-L.
Furthermore, while it's correct that 86% of total patients received early or late DcVAX-L, it is once more wrong that 14% placebo group progressed and went onto other treatments. By simply reading the slide, you will find out that 14% of the placebo group had no DcVAX-L exposure because they either did not have progression/recurrence or had progression/recurrence but chose other treatment than DcVAX-L.
That was an easy slide, how could you infer so many wrong things out of it?
For current shareholders IMO it would be much better...
Reviving old news?
This thing about "if you don't want to take the risk just sell and write off the investment" is IMO one of the most illogical things that I have been reading in this MB, that I would only justify if people is glad about dilution, which actually I don't think is the case.
The fact that you see a great risk/reward from 40M market cap to a 1B market cap itself makes sense, too bad it's based on wrong assumptions, firstly because you give a 100% chance of success of the trial (that's great, but I wonder where did you get that certainty), plus you give a 1B valuation, which is a number that I wonder where that comes from.
But we have discussed this multiple times, and people keep on saying "if you don't like the risk, just sell". Too bad I've heard this when the stock was trading at 1$, then at 0,75$, then at 0,5$, and now at 0,23$.
Well, your post looks to me very well balanced, and indeed brings to light most of the concerns that I believe many shareholders do have.
Many people in this message board keep on talking of how good the science is. I don't personally know how good it is (nor these people really do, either, and nobody will untill final results will be out), but I do believe that if dilution continues like this for a couple of more financing rounds, well, then I guess in my personal opinion that many of shareholders stakes not only will be underwater, but also most likely impossible to recoup. They try to convince themselves that they could, and thus they every once in a while give some astronomical TPs, but that's the dreaming part of the story, the one that happens once in hundreds, but obviously when you own a stock you often think you'll be the lucky one.
I personally have been very negatively impressed by the fact that the co. took time to issue an 8K to confirm that the screening halt has been lifted, but didn't take the chance to clarify once for good why was it issued at all. In my opinion that would have strongly helped shareholders' confidence, and maybe also IMO would have helped to let the co. stand high in front of those who had doubts about the real reason, but that didn't happen.
Why do you think NW put in many millions in this stock a couple of years ago?
Usually in corporate finance past actions are predictive of future actions.
Quite balanced post. Often many shareholders wait for news but they do not arrive in the quality they hope for. I believe April will be the month in which this either sinks close to zero or finally rebounces with strenghts. Whatever the direction, I believe shareholders are close to know it.
That's nice to admit that you didn't account for all OS when throwing in the 50% count, admiting a mistake is a great start to have correct numbers as output.
That said, you still think the stock will ever hit 12? OK, let me tell you once more: LOL! Today it stands at around 0.23.
As you can see moderator deletes my messages as he preferes to have people posting wrong math assumptions. LOL...keep it up flipper, moderator is with you.
Novoc had no approval, just released results. I am comparing oranges with oranges, I understand some people prefer to comprare oranges with apples.
When you write that "the price was at 12 with far less going on for the company that it has now", you are not considering that at that time there were kind of half of the outstanding shares.
So that price in terms of pairing market capitalization would now be reflected by a share price which would be half of that one you mentioned.
I believe this only would be enough to let you understand which one of us is wrong...
Sorry if your investment doesn't make you smile...
It happens when people have lack of arguments, I understand it. But I am glad you have fun with the MB and with your investment, lol.
I bet, I hope you drive with eyes opened and not dreaming like you dream of astronomical TPs...no kidding, sometimes I really ask myself if you are kidding or you really believe what you write, but I tend to opt for the first choice.
I love your humour, and I am glad there is still some after all, lol.
Smith whom?
Flipper are you serious?
I hope not, but if you believe that this could ever go to 12, you should load up the truck as ever, buy it all the way, lol.
12 looks cheap, why not 50? Last time I dreamed of this I woke up in sweat.
That's what "almost" stood for...I wanted to share a verve of optimism...
That's great, because if the Co. will spike 60% as Novoc. did on PIII good results, this could go to almost 0.39$ per share! Uhm...
That looks ugly for the Co., doesn't it?
I am touched that I tend to agree this time with part of the things you wrote.
On top of your post, I still believe that people might hear something on the BMS combo trial for GMB before any Direct news, but this is just my feeling.
Especially because IMO it could finally have some positive effect on the share price.
I tend to agree with your opinion.
Sorry, I had no time to watch it, could you summarize it briefly? Thanks.
I have to admit that sometimes I thinking you are joking. Price reductions, rock bottom prices for each of any combined treatments? What are you talking about? Lol, you are joking, aren't you?
As soon as a BP will jump in with an hefty upfront milestone payment to partner with the Co., I will agree with you, in the meanwhile these are only MB talks, as useless as they are.
Two booths now.
Congratulations...already down 50%...
I love dreams...why not 100$ per share?
Unless the board approves it of course...
When I did read that 84% of 311 patients or 261 received DCVax-L, I fell out of my chair...
He writes that 84% of 311 patients or 261 received DCVax-L
...instead it's IMO 86% of 331 patients or 285 patients!!!
Maybe reading some of your posts while the stock went from 0.35 to sub 0.26 should help your memory, but you know...people have short memory in financial markets. LOL.
It's strange that Pablo gets so mad at a correct consideration of a filing of a few days ago, that instead should IMO be carefully discussed over and over, and then when the sock price plummets he's one of the few really worried about it. Pablo, seriously, you should feel lucky that there are ppl like exwannabe and a few others who keep this MB balanced. If it wasn't for these people you would only hear of astonishing accomplishments while your investment goes to the ground.
It's an old 2014 video. Why don't you also post something of 2010?
Actually that video made think one thing: what has been done in about 3 years ever since? I prefer not to think of it...